The Dean is from the school of thought that believes FEAR & PERCEPTION drive penny stock prices and therefore his 3rd Ivy League Stock Pick ($UVFT) may outperform his other two Ivy League Stock Picks ($IVOB +350% & $BSTK +89%).

The swine flu pandemic and poor air quality have people wearing N95 masks worldwide and the demand for an air purification unit that can kill airborne mold, bacteria, germs and viruses including swine flu is at an all-time high.

In an effort to teach the CollegeStock Community about ultra violet technology and the external marketplace for $UVFT's UV400 ViraGuard The Dean has gathered the following facts:

INDOOR AIR FACTS

(1) According to the Environmental Protection Agency, the air in homes can be up to 100 times more polluted than outdoor air.

(2) The National Academy of Sciences Institute of Medicine reports that exposure to indoor pollutants is a key contributor to the asthma problems of this nation.

(3) Most allergy and asthma sources are passed from person to person through the air.

(4) The air in a single room can contain hundreds of thousands of infectious bacteria, viruses, fungal spores, and contaminants, which can only be seen with a microscope.

(5) Health effects may show up immediately, or after years of exposure to poor indoor air quality. These symptoms include some respiratory diseases, heart disease, and cancer. They may be severely debilitating or fatal.

ULTRAVIOLET TECHNOLOGY FACTS

(1) The disinfection of medical equipment using UV has been a common and reliable practice.

(2) UV disinfection has been determined to be adequate for inactivating bacteria and viruses.

(3) The germicidal effects of UV light cause photochemical damage to DNA and RNA within microorganisms.

(4) “ultraviolet radiation, properly integrated with heating, ventilating, and air conditioning systems, shows the most promise as a widely applicable means of air disinfection,” Richard Riley

$UVFT's UV400 ViraGuard is a Class 2 FDA-Approved Medical Device that uses ultra violet radiation to kill swine flu.

The company's website at http://uvflutech.com/ and the $UVFT Investor Brochure both get The Dean's Seal of Approval as Ivy League Marketing Materials and during January as more penny stock traders learn about $UVFT he's confident a healthy % of traders will ACT!

The Dean is more confident about $UVFT and their ability to generate investor exposure in January than any other stock he's covered and you can either PROFIT from these words or kick yourself for missing out.

The choice is yours.

*Never invest in a stock mentioned by The Dean unless you can afford to lose your entire investment. The Dean has been compensated six hundred thousand shares of rule 144 restricted stock which he's unable to sell until June 2010. He's also agreed to receive a five thousand dollar monthly retainer for communications services. For his full disclaimer visit http://www.collegestock.com/terms/